Biomedical Engineering Reference
In-Depth Information
56. Wu F., Zhou L., and Chen W. R. Host antitumour immune
responses to HIFU ablation.
Int J Hyperthermia
2007;
23:165-71.
57. Gravante G., Sconocchia G., Ong S. L, Dennison A. R., and
Lloyd D. M. Immunoregulatory effects of liver ablation
therapies for the treatment of primary and metastatic liver
malignancies.
Liver Int
2009;29:18-24.
58. Fagnoni F. F., Zerbini A., Pelosi G., and Missale G.
Combination of radiofrequency ablation and immunothe-
rapy.
Front Biosci
2008; 13:369-81.
59. Sabel M. S. Cryo-immunology: A review of the literature
and proposed mechanisms for stimulatory versus suppres-
sive immune responses.
Cryobiology
2009; 58:1-11.
60. Yang R., Reilly C. R., Rescorla F. J., Sanghvi N. T., Fry F. J.,
Franklin T. D. Jr., and Grosfeld J. L. Effects of high-intensity
focused ultrasound in the treatment of experimental neuro-
blastoma.
J Pediatr Surg
1992; 27:246-250.
61. Hu Z., Yang X. Y., Liu Y., Sankin G. N., Pua E. C., Morse
M. A., Lyerly H. K., Clay T. M., and Zhong P. Investigation
of HIFU-induced anti-tumor immunity in a murine tumor
model.
J Transl Med
2007; 5:34.
62. Zhang Y., Deng J., Feng J., and Wu F. Enhancement of anti-
tumor vaccine in ablated hepatocellular carcinoma by high-
intensity focused ultrasound: A preliminary report.
World J
Gastroenterology
2010; 16: in press.
63. Deng J., Zhang Y., Feng J., and Wu F. Dendritic cells loaded
with ultrasound-ablated tumour induce
in vivo
specific
antitumour immune responses.
Ultrasound Med Biol
2010;
36:441-448.
64. Hu Z., Yang X. Y., Liu Y., Morse M. A., Lyerly H. K., Clay T.
M, and Zhong P. Release of endogenous danger signals from
HIFU-treated tumor cells and their stimulatory effects on
APCs.
Biochem Biophys Res Commun
2005; 335:124-131.
65. Kruse D. E., Mackanos M. A., O'Connell-Rodwell C. E.,
ContagC.H., and FerraraK.W. Short-duration-focused
ultrasound stimulation of Hsp70 expression
in vivo.
Phys
Med Biol
2008; 53:3641-3660.
66. Hundt W., O'Connell-Rodwell C. E., Bednarski M. D.,
Steinbach S., and Guccione S.
In vitro
effect of focused
ultrasound or thermal stress on HSP70 expression and
cell viability in three tumor cell lines.
Acad Radiol
2007;
14:859-870.
67. Liu F., Hu Z., Qiu L., Hui C., Li C., Zhong P., and Zhang J.
Boosting high-intensity focused ultrasound-induced anti-
tumor immunity using a sparse-scan strategy that can more
effectively promote dendritic cell maturation.
J Transl Med
2010; 8:7.
68. Zhou P., Fu M., Bai J., Wang Z., and Wu F. Immune response
after high-intensity focused ultrasound ablation for H22
tumor.
J Clin Oncol
2007; 25 (S18):21169.
69. Rosberger D. F., Coleman D. J., Silverman R.,
Woods S., Rondeau M., and Cunningham-Rundles S.
Immunomodulation in choroidal melanoma: Reversal of
inverted CD4/CD8 ratios following treatment with ultra-
sonic hyperthermia.
Biotechnol Ther
1994; 5:59-68.
70. Wang X., and Sun J. High-intensity focused ultrasound in
patients with late-stage pancreatic carcinoma.
Chin Med J
(Engl.)
2002; 115:1332-1335.
71. Wu F., Wang Z. B., Lu P., Xu Z. L., Chen W. Z., Zhu H., and
Jin C. B. Activated anti-tumor immunity in cancer patients
after high intensity focused ultrasound ablation.
Ultrasound
Med Biol
2004; 30:1217-1222.
72. Zhou Q., Zhu X. Q., Zhang J., Xu Z. L., Lu P., and Wu F.
Changes in circulating immunosuppressive cytokine levels
of cancer patients after high intensity focused ultrasound
treatment.
Ultrasound Med Biol
2008; 34:81-88.
73. Kramer G., Steiner G. E., Grobl M., Hrachowitz K.,
Reithmayr F., Paucz L., Newman M., Madersbacher S.,
Gruber D., Susani M., and Marberger M. Response to sub-
lethal heat treatment of prostatic tumor cells and of pros-
tatic tumor infiltrating T-cells.
Prostate
2004; 58:109-120.
74. Wu F., Wang Z. B., Cao Y. D., Zhou Q., Zhang Y., Xu Z.
L., and Zhu X. Q. Expression of tumor antigens and heat-
shock protein 70 in breast cancer cells after high-inten-
sity focused ultrasound ablation.
Ann Surg Oncol
2007;
14:1237-1242.
75. Xu Z. L., Zhu X. Q., Lu P., Zhou Q., Zhang J., and Wu F.
Activation of tumor-infiltrating antigen presenting cells by
high intensity focused ultrasound ablation of human breast
cancer.
Ultrasound Med Biol
2009; 35: 50-57.
76. Lu P., Zhu X. Q., Xu Z. L., Zhou Q., Zhang J., and Wu F.
Increased infiltration of activated tumor-infiltrating lym-
phocytes after high intensity focused ultrasound ablation of
human breast cancer.
Surgery
2009; 145:286-93.
77. Dunn F. Attenuation and speed of ultrasound in lung.
J
Acoust Soc Am
1974; 56: 1638-1639.
78. Wells P. N. T., Ed.,
Biomedical ultrasonics,
Academic Press,
Inc. London (1977).
79. Hill C. R., Bamber J. C., and ter Haar G. R., Eds.,
Physical
principles of medical ultrasound,
2nd ed. John Wiley & Sons
Ltd., Chichester (2004).
80. Goss S. A., Frizzell L. A., and Dunn F. Ultrasonic absorption
and attenuation in mammalian tissues.
Ultrasound Med Biol
1979; 5:181-186.
81. Goss S. A., Johnson R. L., and Dunn F. Comprehensive
compilation of empirical ultrasonic properties of mamma-
lian tissues.
J Acoust Soc Am
1978; 64:423-457.
82. Goss S. A., Johnson R. L., and Dunn F. Compilation of
empirical ultrasonic properties of mammalian tissues.
J Acoust Soc Am
1980; 68:93-108.
83. Kikuchi Y., Uchida R., Tanaka K., and Wagai T. Early can-
cer diagnosis through ultrasonics.
J Acoust Soc Am
1957;
29:824-833.
84. Calderon C., Vilkomerson D., Mezrich R., Etzold K. F.,
Kingsley B., and Haskin M. Differences in the attenuation
of ultrasound by normal, benign, and malignant breast tis-
sue.
J Clin Ultrasound
1976; 4: 249-254.
85. Cline H. E., Schenek J. F., Hynynen K., Watkins R. D.,
Schenek J. F., and Jolesz F. A. MR-guided focused ultra-
sound surgery.
J Comput Assist Tomogr
1992; 16:956-965.
